UDP-Gal: bGlcNAcb1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumor antigen recognized by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumor.(共著). Br. J. Cancer. 2002. in press
Development of cancer vaccine by tumor rejection antigens(共著)
International Reviews of Immunology. eds : K. Kumagai and S.Kasakura, Springer-Verlag, New York 1997
Expression of MAGE-1 and -4 proteins in normal tissues and various cancers.(共著)
Melanogenesis and Malignant Melanoma : Biochemistry, Cell Biology, Molecular Biology, Pathophysiology, Diagnosis and Treatment eds : Holix, Hearing V. J. and Nakayama J. ELSEVIER 1996
Preparation and use of liposones in immunological studies. (共著)
Liposome Technology, 2nd ed. vol III, CRC Press 1993
Glycolipid antigens and cell differentiation.(共著)
Annual Review, Immunology,1988 (Japanese). Cyu-gai-igakusya, (eds:Kikuchi K, Yata J, and Okumura K.) 1988
Carl R. Alving, Shigeki Shichijo, Inger Mattsby-Baltzer: Preparation and use of liposomes in immunological studies. Liposome Technology, 2nd Edition, Volume?, Chapter 21, pp157-175. 1984. Edited by Gregory Gregoriadis, Ph. D., CRC Press, Boca Raton. fo・・・
1984
Development of monoclonal antibodies for clinical treatment
Education (2):
- 1973 Saga University Faculty of Science and Engineering
Saga University Faculty of Science and Engineering
Professional career (1):
Doctor (Medicine) (Kurume University)
Association Membership(s) (10):
基盤的癌免疫研究会
, 日本バイオセラピイ学会
, 日本生化学会
, 日本癌学会
, 日本免疫学会
, 米国免疫学会
, The American Association of Immunologists
, The Japanese Cancer Association
, The Japanese Society for Immunology
, The Japanese Biochemical Society